Effect of rt-PA intravenous thrombolysis on the prognosis of patients with minor ischemic stroke.


Journal

Neurological research
ISSN: 1743-1328
Titre abrégé: Neurol Res
Pays: England
ID NLM: 7905298

Informations de publication

Date de publication:
Aug 2021
Historique:
pubmed: 14 4 2021
medline: 8 1 2022
entrez: 13 4 2021
Statut: ppublish

Résumé

The evidence of rt-PA intravenous thrombolysis in patients with minor ischemic stroke (MIS) is still controversial. This study aims to investigate the effect of rt-PA intravenous thrombolysis on the prognosis of patients with MIS. We continuously enrolled and analyzed patients with MIS admitted into our hospital within 24 h after symptom onset between January 2016 and December 2018, including 96 patients received intravenous thrombolysis within 4.5 h after symptom onset and 84 patients not received intravenous thrombolysis. A favorable long-term outcome was a 90-day mRS score of 0-1. Good short-term outcome was a 7-day NIHSS score of 0 or less than NIHSS onset. There were no statistical differences between two groups of patients' age, gender, history of hypertension, coronary heart disease, atrial fibrillation, smoking, drinking, and baseline NIHSS score. Patients with history of stroke (22.62% vs. 10.42%, Patients with MIS received intravenous thrombolysis may be associated with earlier neurological improvement, but might has no significant effect on long-term prognosis. The level of neutrophil ratio and CRP at admission are risk factors determining the prognosis, which requires further research.

Identifiants

pubmed: 33847231
doi: 10.1080/01616412.2021.1908672
doi:

Substances chimiques

Fibrinolytic Agents 0
C-Reactive Protein 9007-41-4
Tissue Plasminogen Activator EC 3.4.21.68

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

653-658

Auteurs

Yingying Han (Y)

Department of Neurology, East Hospital, Tongji University School of Medicine, Shanghai, China.

Gang Li (G)

Department of Neurology, East Hospital, Tongji University School of Medicine, Shanghai, China.

Yueyu Tang (Y)

Department of Neurology, East Hospital, Tongji University School of Medicine, Shanghai, China.

Bei Zhang (B)

Department of Neurology, East Hospital, Tongji University School of Medicine, Shanghai, China.

Yiqiang Zhan (Y)

Department of Neurology, Yang-Si Hospital, Shanghai, China.

Chunfang Zhang (C)

Department of Shanghai Pudong Medical Emergency Center, Shanghai, China.

Lian Zuo (L)

Department of Neurology, East Hospital, Tongji University School of Medicine, Shanghai, China.

Wei Wu (W)

Department of Neurology, Qi-Lu Hospital of Shandong University and Brain Science Research Institute, Shandong University, Shandong, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH